ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 118 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.17 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,122,000 | +218.8% | 99,921 | +116.0% | 0.62% | +846.2% |
| Q1 2016 | $1,293,000 | -68.1% | 46,258 | -59.4% | 0.06% | -70.9% |
| Q4 2015 | $4,058,000 | -85.2% | 113,838 | -86.8% | 0.22% | -74.3% |
| Q4 2014 | $27,446,000 | +106.2% | 864,437 | +46.7% | 0.87% | +51.8% |
| Q2 2014 | $13,311,000 | +18.1% | 589,264 | +27.2% | 0.57% | -9.7% |
| Q1 2014 | $11,268,000 | -19.1% | 463,146 | -16.9% | 0.63% | -28.8% |
| Q4 2013 | $13,920,000 | +18.8% | 557,013 | +30.6% | 0.89% | +16.5% |
| Q3 2013 | $11,719,000 | -19.7% | 426,600 | -47.0% | 0.76% | -21.8% |
| Q2 2013 | $14,597,000 | – | 804,255 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |